James Basta, EVP, General Counsel at Intellia Therapeutics, Inc. (NTLA), sold 14,148 shares at $12.18 ($172K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $172k NTLA by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.18 | 7,074 | $86K | 50.0% |
| 2 | $12.18 | 7,074 | $86K | 50.0% |
| Total | $12.18 avg | 14,148 | $172K | 100% |
| Filing → |
| NTLA | SELL | 2025-03-04 | $23K | — | Filing → |
| NTLA | SELL | 2024-03-05 | $152K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $224K | — | Filing → |